GLENDALE, CA - March 16, 2026 - LigoLab, a laboratory informatics company headquartered in Glendale, reported key ...

Raleigh, NC - March 16, 2026 - PRESSADVANTAGE - Porter Ophthalmology has opened a dedicated Office-Based Surgery suite ...

LTR Pharma recently announced the dosing of the first patients in the Phase II study of SPONTAN ®, which is evaluating the safety, tolerability and pharmacokinetic profile of LTR Pharma’s rapid acting ...

The goal in the world of global health is to bring an end to this scourge by 2030. A new drug looks as if it could do the job ...

Nelson Fernandez and B&N Talent Partners Joins the Dimensional Search Network of Offices B&N Talent Partners, an executive ...

Explainability tools are commonly used in AI development to provide visibility into how models interpret data. In healthcare machine learning systems, explainability techniques may highlight factors ...

ORLANDO, FL, UNITED STATES, March 16, 2026 /EINPresswire.com/ -- Orlando Leader Champions Maternal and Neonatal Care, ...

Rentschler taps biopharma vet to lead ops. Rentschler Biopharma, the German CDMO with offices in Massachusetts and Stevenage, ...

Alto Neuroscience secures $120M to advance novel depression therapy ALTO-207 through Phase 3 trials, aiming for FDA ...

Early clinical proof-of-concept for WEE1 inhibitor APR-1051 in the ongoing ACESOT-1051 trial with two partial responders at first scan in endometrial cancer patients with PPP2R1A mutationClinical team ...

Herantis Pharma Plc ('Herantis'), a clinical-stage company developing disease-modifying therapies to stop the progression of Parkinson’s disease, announces that its Chief Scientific Officer, Henri ...

Total Revenue and Adjusted EBITDA1,2 above high end of previously provided guidance Total End of Period Subscribers of 2.8 million; End of Period Clinical Subscribers of 130 thousand, up 42% year-over ...